Kura Oncology (KURA) Current Taxes (2024 - 2026)
Kura Oncology (KURA) posted quarterly Current Taxes of $239000.0 for Q1 2026, down 89.55% year-over-year from $2.3 million in Q1 2025, and little changed quarter-over-quarter from $239000.0 in Q4 2025.
Kura Oncology (KURA) Current Taxes (2024 - 2026) Analysis & Trends
Kura Oncology (KURA) has reported Current Taxes for 3 consecutive years, with $239000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Taxes fell 89.55% year-over-year to $239000.0; the TTM figure through Mar 2026 stood at $239000.0 (down 89.55% YoY), while the FY2025 annual figure was $239000.0, down 88.4% from the prior year.
- Current Taxes held at $239000.0 in Q1 2026 per KURA's latest filing, from $239000.0 in the prior quarter.
- Across five years, Current Taxes topped out at $2.3 million in Q1 2025 and bottomed at $239000.0 in Q4 2025.
- Historically, Current Taxes has averaged $1.2 million across 3 years, with a median of $1.2 million in 2024.
- Annual changes were most pronounced in 2025 — Current Taxes sank 88.4% — and 2026, when it slumped 89.55%.
- Kura Oncology's Current Taxes stood at $2.1 million in 2024, then tumbled by 88.4% to $239000.0 in 2025, then changed by 0.0% to $239000.0 in 2026.
- Business Quant data shows KURA's Current Taxes at $239000.0 in Q1 2026, $239000.0 in Q4 2025, and $2.3 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 49.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 76.32 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 59,089.99 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Kura Oncology | 966.11 Mn | 966.11 Mn | 20.63 Mn | 59,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 59,000.00 |
| Mar 31, 2026 | 239,000.00 |
| Dec 31, 2025 | 239,000.00 |
| Mar 31, 2025 | 2.29 Mn |
| Dec 31, 2024 | 2.06 Mn |